Title:
DRUG TARGETING FIBROBLAST ACTIVATION PROTEIN AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2024/078592
Kind Code:
A1
Abstract:
The present invention relates to a compound targeting fibroblast activation protein (FAP) as shown in formula (X) and a use thereof, and further relates to a pharmaceutical composition containing the compound and a use. The compound or the pharmaceutical composition can be used for diagnosing and/or treating and/or preventing one or more tumors, cancers or cells expressing FAP.
Inventors:
YAN CHENGLONG (CN)
FANG PENG (CN)
YU SHANYOU (CN)
ENG WAI-SI (CN)
YANG SI (CN)
YU DEFENG (CN)
FANG PENG (CN)
YU SHANYOU (CN)
ENG WAI-SI (CN)
YANG SI (CN)
YU DEFENG (CN)
Application Number:
PCT/CN2023/124323
Publication Date:
April 18, 2024
Filing Date:
October 12, 2023
Export Citation:
Assignee:
NORROY BIOSCIENCE CO LTD (CN)
International Classes:
C07D491/22; A61K31/40; A61K31/4709; A61K31/496; A61P35/00; C07D401/14
Attorney, Agent or Firm:
TSINGYIHUA INTELLECTUAL PROPERTY LLC (CN)
Download PDF:
Previous Patent: CONDENSER CYLINDER AND PHOTOGRAPHY LIGHTING EFFECT APPARATUS
Next Patent: COMMUNICATION METHOD AND COMMUNICATION APPARATUS
Next Patent: COMMUNICATION METHOD AND COMMUNICATION APPARATUS